Head-To-Head Comparison: Orthofix International (OFIX) versus Syneron Medical (ELOS)
Orthofix International (NASDAQ: OFIX) and Syneron Medical (NASDAQ:ELOS) are both small-cap medical equipment, supplies & distribution – nec companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.
This table compares Orthofix International and Syneron Medical’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of recent recommendations for Orthofix International and Syneron Medical, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Orthofix International currently has a consensus price target of $53.30, indicating a potential downside of 2.56%. Syneron Medical has a consensus price target of $11.00, indicating a potential upside of 0.00%. Given Syneron Medical’s higher possible upside, analysts plainly believe Syneron Medical is more favorable than Orthofix International.
Insider and Institutional Ownership
94.6% of Orthofix International shares are owned by institutional investors. Comparatively, 69.2% of Syneron Medical shares are owned by institutional investors. 5.6% of Orthofix International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Volatility and Risk
Orthofix International has a beta of 0.14, indicating that its share price is 86% less volatile than the S&P 500. Comparatively, Syneron Medical has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500.
Valuation and Earnings
This table compares Orthofix International and Syneron Medical’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Orthofix International||$409.79 million||2.43||$3.05 million||$0.02||2,735.00|
Orthofix International has higher revenue and earnings than Syneron Medical.
Orthofix International beats Syneron Medical on 8 of the 10 factors compared between the two stocks.
Orthofix International Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, Samba-Screw System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.
Syneron Medical Company Profile
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company’s products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.
Receive News & Ratings for Orthofix International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International and related companies with MarketBeat.com's FREE daily email newsletter.